Skip to main navigation
Skip to search
Skip to main content
Houston Methodist Scholars Home
Home
Experts
Research units
Cores
Projects
Research output
Prizes
Search by expertise, name or affiliation
Next-generation sequencing and immunotherapy biomarkers: A medical oncology perspective
Eric Bernicker
Academic Institute
Dr. Mary and Ron Neal Cancer Center
Department of Medicine
Houston Methodist Hospital
Houston Methodist
Weill Cornell Medical College
Research output
:
Contribution to journal
›
Article
›
peer-review
13
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Next-generation sequencing and immunotherapy biomarkers: A medical oncology perspective'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Immunotherapy
100%
Neoplasm
100%
Biological Marker
100%
Next Generation Sequencing
100%
Medical Oncology
100%
Malignant Neoplasm
50%
Non Small Cell Lung Cancer
50%
Pathologist
50%
Immune Checkpoint Inhibitor
50%
Clinician
50%
Treatment Response
50%
Immune System
50%
Immunity
50%
Targeted Therapy
50%
Gene Mutation
50%
Immunology and Microbiology
Next Generation Sequencing
100%
Immunotherapy
100%
Immunity
100%
Gene Mutation
50%
Immune System
50%
Keyphrases
System Attack
50%
Tumor-immune Interaction
50%
Biochemistry, Genetics and Molecular Biology
Immune Checkpoints
50%